TMO monthly performance report
Check TMO's monthly returns, drawdown, and seasonality trends — updated every month.
TMO monthly report
—
Key takeaways
- Thermo Fisher Scientific (TMO) closed November 2026 at $699.44, up 0.35% for the month and +18.95% over the trailing 12 months.
- Year-to-date, TMO is +20.71%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +25.88% versus its 200-day moving average ($555.63), a bullish technical signal.
- Over the past three years, TMO has underperformed the S&P 500 by −15.86%, with a relative strength index reading of 91.4.
- Win rate over the trailing 39 months stands at 53.8% — 21 positive months versus 18 negative months.
Thermo Fisher Scientific ended November 2026 at $699.44, posting a monthly return of +0.35%. The S&P 500 returned +0.19% over the same window, leaving relative performance at +0.16%.
The current quarter stands at +3.61% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +25.88% versus the 200-day moving average ($555.63).
Year-to-date, TMO is +20.71% against SPY +11.03%, a gap of +9.68%. The stock is currently −3.86% below its 52-week high, with maximum 3-year drawdown at −37.48%.
| Period | TMO | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −2.55% | −0.35% | −2.19% |
| 1 Week | +3.32% | +3.29% | +0.03% |
| 1 Month | +0.35% | +0.19% | +0.16% |
| 3 Months | +18.89% | −2.48% | +21.37% |
| 6 Months | +56.81% | +2.00% | +54.82% |
| YTD | +20.71% | +11.03% | +9.68% |
| 12 Months | +18.95% | +10.79% | +8.16% |
| 3 Years | +55.98% | +71.83% | −15.86% |
| Rank | Month | Return |
|---|---|---|
| #1 | Oct 2025 | +16.98% |
| #2 | Jul 2025 | +15.35% |
| #3 | Jan 2025 | +14.90% |
| #4 | Jul 2026 | +14.55% |
| #5 | Nov 2023 | +11.46% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2025 | −13.79% |
| #2 | Oct 2023 | −12.13% |
| #3 | Oct 2024 | −11.68% |
| #4 | Feb 2025 | −11.51% |
| #5 | Feb 2026 | −9.94% |
| Quarter | Return |
|---|---|
| Q3 2025 | +19.62% |
| Q4 2025 | +19.47% |
| Q1 2026 | −15.17% |
| Q2 2026 | +2.00% |
| Q3 2026 | +34.64% |
| Q4 2026 (QTD) | +3.61% |
| Year | Return |
|---|---|
| 2023 | −3.61% |
| 2024 | −1.99% |
| 2025 | +11.38% |
| 2026 | +20.71% |
| Metric | Value |
|---|---|
| 52-Week High | $727.56 (2026-11-11) |
| 52-Week Low | $435.27 (2026-05-18) |
| Current Price | $699.44 |
| 200-Day Moving Average | $555.63 |
| Price vs 200DMA | +25.88% |
| 3-Year Maximum Drawdown | −37.48% (2025-06-17) |
| Current Drawdown from 52W High | −3.86% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 91.4 |
| 3-Year Excess Return vs S&P 500 | −15.86% |
| RS Peak | 115.9 (Mar 2024) |
| RS Trough | 58.6 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was TMO's return for this report period?
TMO returned +0.35% in the latest monthly window ending 2026-11-12.
Has TMO outperformed SPY year to date?
YTD TMO: +20.71% vs SPY: +11.03%.
What is TMO's 12-month return?
+18.95% over the trailing 12 months.
Is TMO above or below its 200-day moving average?
Price is +25.88% versus 200DMA ($555.63).
What is the maximum drawdown in the 3-year window?
−37.48% on 2025-06-17.